Eli Lilly (LLY) said the response in India to its Mounjaro has been “positive,” adding it is focused on meeting demand for the drug in the country, Rishika Sadam of Reuters reports.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LLY:
- Eli Lilly (LLY) to Offer Higher Doses of Its Weight-Loss Drug on Website
- 3 Mega Cap Stocks with Potential to Beat the Market, 6/19/25
- Eli Lilly & Co: Strategic Growth Through VERV Acquisition and Pioneering Gene Editing
- Eli Lilly (LLY) Enters Gene-Editing Space with Verve Therapeutics Acquisition
- SanDisk initiated, Analog Devices upgraded: Wall Street’s top analyst calls